Increased macrophage activity in coronary plaques in patients with acute coronary syndrome and familial

Toshiyuki Iwaya1, Yoshiyasu Minami1, Kiyoshi Asakura1

  • 1Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan.

Insights

Familial hypercholesterolemia (FH) patients with acute coronary syndrome (ACS) show more coronary plaques with macrophages, especially in non-culprit segments. This finding may explain their higher risk of recurrent cardiovascular events.

Area of Science:

  • Cardiovascular Medicine
  • Atherosclerosis Research
  • Genetics and Lipid Metabolism

Background:

  • Familial hypercholesterolemia (FH) significantly increases the risk of premature acute coronary syndrome (ACS) and recurrent cardiovascular events.
  • Understanding the specific plaque characteristics in FH patients is crucial for risk stratification and management.

Purpose of the Study:

  • To investigate the morphological characteristics of coronary artery plaques, focusing on macrophage presence and activity, in patients with FH and ACS.
  • To compare plaque features between patients with and without FH using optical coherence tomography (OCT).

Main Methods:

  • A cohort of 259 ACS patients undergoing percutaneous coronary intervention received optical coherence tomography (OCT) imaging.
  • Culprit and non-culprit coronary plaques were analyzed for macrophage content and activity in patients with and without FH.
  • Statistical comparisons were made between the FH and non-FH groups.

Main Results:

  • Patients with FH (8.9%) exhibited a numerically higher prevalence of macrophages in culprit plaques compared to non-FH patients.
  • Significantly higher prevalence of macrophages and greater macrophage activity were observed in non-culprit plaques of FH patients.
  • Non-culprit plaques in FH patients also showed a higher prevalence of layered plaque morphology.

Conclusions:

  • Familial hypercholesterolemia patients with ACS present with a greater burden of coronary plaques containing macrophages, particularly in non-culprit segments.
  • These findings suggest that enhanced macrophage activity in coronary plaques may contribute to the elevated risk of recurrent events observed in FH.
  • OCT imaging provides valuable insights into plaque composition and its association with cardiovascular risk in FH.
Abstract

Related Concept Videos

Inflammation01:38

Inflammation

Overview
61.4K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
340
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
795
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
847
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
325
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
293